XBiotech reports positive Phase II TASKIN trial results
XBiotech announced positive final efficacy results from its investigator-sponsored TASKIN trial in refractory metastatic colorectal cancer.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.